Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    An underlying site revision updated from v3.3.3 to v3.3.4; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:44:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:33:23.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Minor site version update: Revision to v3.3.2 with no substantive changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:12.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Minor editorial updates: PubMed publication notes now indicate automatic filling from PubMed and Revision: v3.3.1; the previous statement about PubMed publications and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:42:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removal of a site-wide government funding/operating status notice from the study page.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:59.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Updates appear to be limited to metadata changes (dates, references); core study content remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:13.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.